SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing intense volatility after FDA briefing documents cast significant doubt on the clinical efficacy of deramiocel, leading investors to re-evaluate the company's prospects ahead of a critical upcoming advisory committee meeting. Community discussion is sharply divided between those who believe the FDA's analysis relies on obsolete statistical data and those who fear the negative regulatory tone signals an imminent rejection or requirement for a new trial.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

NVIDIA is facing intense selling pressure as investors scrutinize the company's multi-billion dollar financing commitments to OpenAI and growing geopolitical concerns regarding China's semiconductor capabilities. While the community is sharply divided between those calling this a long-term buying opportunity and others citing an 'AI bubble' fueled by circular financing, traders remain highly focused on whether the stock can reclaim critical support levels.

Adobe, Inc. is a global technology company, which engages in the provision of digital marketing and media solutions. It operates through the following segments: Digital Media, Digital Experience, and Publishing and Advertising. The Digital Media segment offers products and services that enable individuals, teams, businesses, and enterprises to create, publish, and promote content anywhere and accelerate productivity by transforming view, share, engage with and collaborate on documents and creative content. The Digital Experience segment focuses on integrated platform and set of products, services, and solutions that enable businesses to create, manage, execute, measure, monetize, and optimize customer experiences that span from analytics to commerce. The Publishing and Advertising segment includes legacy products and services that address diverse market opportunities, including eLearning solutions, technical document publishing, web conferencing, document and forms platform, web app development, high-end printing, and Adobe Advertising offerings. The company was founded by Charles M. Geschke and John E. Warnock in December 1982 and is headquartered in San Jose, CA.

Adobe Inc

Adobe is experiencing heightened volatility and active community debate as investors parse the impact of analyst downgrades against a perceived valuation discount in the SaaS sector. Traders are closely monitoring the stock's ability to sustain recent technical breakouts while weighing broader concerns regarding AI disruption against the company's strong cash flow and potential leadership changes.

Salesforce, Inc. engages in the design and development of cloud-based enterprise software for customer relationship management. Its solutions include sales force automation, customer service and support, marketing automation, digital commerce, community management, collaboration, industry-specific solutions, and salesforce platform. The firm also provides guidance, support, training, and advisory services. The company was founded by Marc Russell Benioff and Parker Harris in 1999 and is headquartered in San Francisco, CA.

Salesforce Inc

Salesforce is gaining renewed interest as analysts and investors debate whether the recent sector-wide selloff in software has created an attractive valuation entry point for high-quality enterprise platforms. The community is actively discussing the stock's long-term potential as a workflow and data leader in the AI era, while navigating ongoing skepticism regarding near-term growth trajectories and broader software rotation trends.

Palantir Technologies, Inc. engages in the business of building and deploying software platforms that serve as the central operating systems for its customers. It operates through the Commercial and Government segments. The Commercial segment focuses on customers working in non-government industries. The Government segment is involved in providing services to customers that are the United States government and non-United States government agencies. Its platforms are widely used in areas such as defense, intelligence, healthcare, energy, and financial services, supporting data integration, large-scale analytics, and operational decision-making. The company was founded by Alexander Ceadmon Karp, Peter Andreas Thiel, Stephen Cohen, Joseph Lonsdale, and Nathan Dale Gettings in 2003 and is headquartered in Aventura, FL.

Palantir Technologies Inc - Ordinary Shares - Class A

Palantir Technologies Inc

Palantir is currently experiencing intense volatility as institutional investors rotate capital between semiconductors and AI software, with community sentiment deeply divided between long-term holders betting on sustained growth and active traders speculating on price swings heading into upcoming earnings. The primary catalysts driving discussion include the company's expanding role in government and enterprise defense infrastructure, alongside active debates regarding the sustainability of current AI valuations.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending due to heightened geopolitical tensions in the Middle East and concerns over oil supply chain disruptions, particularly regarding the Strait of Hormuz and Red Sea shipping routes. Market participants are actively debating the impact of these tensions on global energy prices, while closely monitoring official statements regarding potential military escalation and diplomatic negotiations.

Shopify, Inc. is a global commerce company that provides essential internet infrastructure for commerce, offering trusted tools to start, scale, market, and run a retail business of any size. The Company's software enables merchants to run their business across all of their sales channels, including web and mobile storefronts, physical retail locations, social media storefronts and marketplaces. The Shopify platform provides merchants with a single view of their business across all of their sales channels and enables them to manage products and inventory, process orders and payments, fulfill and ship orders, build customer relationships, source products, leverage analytics and reporting and access financing, all from one integrated back office. The company was founded on September 28, 2004 and is headquartered in Ottawa, Canada.

Shopify Inc - Ordinary Shares - Class A (Sub Voting)

Shopify Inc

Shopify is seeing increased volatility and investor attention as the market debates its valuation against potential competitive threats from AI-driven commerce tools. While some traders are focused on technical support levels and recent share buyback activity, others are actively discussing the stock's long-term potential as a critical e-commerce infrastructure player.

Atlassian Corp. is a holding company, which engages in providing team collaboration and productivity software. Its products include Jira Software, Confluence, Jira Service Management, and Loom. The company was founded by Michael Cannon-Brookes and Scott Farquhar in October 2002 and is headquartered in San Francisco, CA.

Atlassian Corporation - Ordinary Shares - Class A

Atlassian Corporation Plc

Atlassian is trending following a strong fiscal third-quarter earnings beat that ignited a massive post-market rally and triggered a broader relief rally across the enterprise software sector. The community is actively debating whether this performance marks the end of the so-called 'SaaS-pocalypse' and the beginning of a sector-wide rotation as investors weigh evidence of sustained cloud demand against fears of AI-driven disruption.

Karman Holdings, Inc. engages in the design, testing, manufacturing, and sale of dependable missile systems. It offers Payload Protection & Deployment Systems, Aerodynamic Interstage Systems, and Propulsion Systems. The company was founded on August 20, 2020 and is headquartered in Huntington Beach, CA.

Karman Holdings Inc.

Karman Holdings Ord Shs

Karman Holdings is seeing heightened interest following a string of positive analyst updates, contract wins, and its recent inclusion in the S&P 600, which has fueled community discussions about a potential defense-sector breakout. Investors are closely monitoring the technical setup and long-term backlog growth, with many actively debating whether the current price action signals a lasting trend reversal or further consolidation.

Legend Biotech Corp. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, manufacturing, and commercialization of novel therapies for oncology and other indications. The firm develops advanced cell therapies across a diverse array of technology platforms, including autologous and allogeneic chimeric antigen receptor T-cell, gamma-delta T cell and natural killer cell-based immunotherapy. It operates through the following geographical segments: United States of America, China, and Other. The company was founded in 2014 and is headquartered in Somerset, NJ.

Legend Biotech Corp - ADR

Legend Biotech

Legend Biotech is facing intense downward pressure and recent share price weakness following J&J's announcement of new clinical data for a combo therapy that potentially competes with Carvykti. The community is actively debating the company's valuation, questioning if this serves as a prime buyout opportunity or if the stock is struggling due to competitive threats and lack of leadership transparency.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

IQVIA Gears Up to Report Q2 Earnings: What's in the Offing?

IQV heads into its Q2'26 earnings release with y/y revenue and EPS growth expected, supported by AI adoption, drug launches and high-margin segment gains.

Earnings Preview: Veracyte (VCYT) Q2 Earnings Expected to Decline

Veracyte (VCYT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IQVIA Holdings (IQV) Reports Next Week: Wall Street Expects Earnings Growth

IQVIA (IQV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, shared recommendations for strengthening the United States as a leading destination for early clinical development during the...

IQV vs. PEN: Which Stock Is the Better Value Option?

Here's Why IQVIA Holdings (IQV) is a Strong Value Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026

IQVIA Holdings Inc. (IQVIA) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its second-quarter 2026 financial results before the market opens on Tuesday, July 28, 2026...

ICON Stock and the CRO Trends Shaping Its Next Growth Phase

ICLR is tapping CRO demand, AI workflows and wider trial access, but uneven revenue trends and margin resets keep its earnings recovery in focus.

Top Analyst Reports for Amazon.com, Walmart & American Express

Amazon.com's AI push, global expansion and diversified businesses support growth, but rising AI spending, debt and competition pose challenges.

Is ICLR Stock a Value Trap or Turnaround After an Earnings Reset?

ICON trades below its five-year median, but weaker 2026 guidance, control issues and leverage keep the stock in wait-and-see territory.

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission-critical information, technology solutions, and real-world evidence services to the company's life sciences clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial-related services. The Contract Sales and Medical Solutions segment offers healthcare provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1950 and is headquartered in Durham, NC.

IQVIA Holdings Inc

Retail Raves About IQVIA Holdings After Firm Raises Revenue, Profit Guidance

Equity

Bullish Sentiment

Above 2%

1% to 2%

Below 1%

Negative growth

The Q2 2026 GDP advance estimate lands Thursday, July 30, with the Atlanta Fed's GDPNow model nowcasting just 1.7% annualized growth, a sharp step-down from the roughly 3% pace it projected earlier in the quarter. Where do you think GDP comes in? Vote and explain your reasoning in the comments.

The Q2 GDP advance estimate releases Thursday. Atlanta Fed&#39;s GDPNow model is pointing to just 1.7% growth, down sharply from its ~3% nowcast earlier this quarter. Where do you think GDP comes in?

Stocktwits

The Q2 GDP advance estimate releases Thursday. Atlanta Fed's GDPNow model is pointing to just 1.7% growth, down sharply from its ~3% nowcast earlier this quarter. Where do you think GDP comes in?

Feed

News

Sentiment

Earnings

Fundamentals

Info

IQVIQVIA Holdings Inc

Latest IQV News